Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Surgical Treatment for Refractory GERD
NCT01265550Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of baclofen, desipramine in gastroesophageal reflux disease (GERD), sponsored by VA Office of Research & Development. Started Aug 2012; status: completed.
02
Drugs
baclofendesipramine
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01265550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265550.